1. AHRO : Austin Health Research Online

Jonathan S Cebon

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Jonathan S Cebon
Full Name
Cebon, Jonathan S
 
Department
 
ORCID
Loading... 3 0 20 0 false

Publications

Refined By:
Fulltext:  With Fulltext

Results 1-13 of 13 (Search time: 0.018 seconds).

Publication YearTitleAuthor(s)
112-Apr-2021Combination immunotherapy with ipilimumab and nivolumab in patients with advanced adrenocortical carcinoma: a subgroup analysis of CA209-538.Klein, Oliver ; Senko, Clare ; Carlino, Matteo S; Markman, Ben; Jackett, Louise A ; Gao, Bo; Lum, Caroline; Kee, Damien ; Behren, Andreas; Palmer, Jodie ; Cebon, Jonathan S 
29-Sep-2016Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populationsGrasso, Carole; Anaka, Matthew; Hofmann, Oliver; Sompallae, Ramakrishna; Broadley, Kate; Hide, Winston; Berridge, Michael V; Cebon, Jonathan S ; Behren, Andreas; McConnell, Melanie J
37-Feb-2015Low-dose cyclophosphamide enhances antigen-specific CD4(+) T cell responses to NY-ESO-1/ISCOMATRIX™ vaccine in patients with advanced melanoma.Klein, Oliver ; Davis, Ian D; McArthur, Grant A; Chen, Li; Haydon, Andrew; Parente, Phillip; Dimopoulos, Nektaria; Jackson, Heather M; Xiao, Kun; Maraskovsky, Eugene; Hopkins, Wendie; Stan, Rodica; Chen, Weisan; Cebon, Jonathan S 
411-Oct-2013Intratumoral genetic heterogeneity in metastatic melanoma is accompanied by variation in malignant behaviors.Anaka, Matthew; Hudson, Christopher; Lo, Pu-Han; Do, Hongdo; Caballero, Otavia L; Davis, Ian D; Dobrovic, Alexander ; Cebon, Jonathan S ; Behren, Andreas
526-Aug-2012Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapy.Knights, Ashley J; Fucikova, Jitka; Pasam, Anupama; Koernig, Sandra; Cebon, Jonathan S 
623-Jun-2011Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™.Nicholaou, Theo; Chen, Weisan; Davis, Ian D; Jackson, Heather M; Dimopoulos, Nektaria; Barrow, Catherine; Browning, Judy; Macgregor, Duncan; Williams, David; Hopkins, Wendie; Maraskovsky, Eugene; Venhaus, Ralph; Pan, Linda; Hoffman, Eric W; Old, Lloyd J; Cebon, Jonathan S 
729-Apr-2010Processing and cross-presentation of individual HLA-A, -B, or -C epitopes from NY-ESO-1 or an HLA-A epitope for Melan-A differ according to the mode of antigen delivery.Robson, Neil C; McAlpine, Tristan; Knights, Ashley J; Schnurr, Max; Shin, Amanda; Chen, Weisan; Maraskovsky, Eugene; Cebon, Jonathan S 
2817-Feb-2009Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells.Gedye, Craig; Quirk, Juliet; Browning, Judy; Svobodová, Suzanne; John, Thomas ; Sluka, Pavel; Dunbar, P Rod; Corbeil, Denis; Cebon, Jonathan S ; Davis, Ian D
913-Jan-2009Activin-A attenuates several human natural killer cell functions.Robson, Neil C; Wei, Heng; McAlpine, Tristan; Kirkpatrick, Naomi; Cebon, Jonathan S ; Maraskovsky, Eugene
1019-Nov-2005A phase 1 and pharmacokinetic study of gemcitabine and oxaliplatin in patients with solid tumors.Gan, Hui K ; Mitchell, Paul L R ; Galettis, Peter; Davis, Ian D; Cebon, Jonathan S ; de Souza, Paul; Links, Matthew
118-Jul-2005Impact of 2-deoxy-2[F-18]fluoro-D-glucose Positron Emission Tomography on the management of patients with advanced melanoma.Harris, Marion T; Berlangieri, Salvatore U ; Cebon, Jonathan S ; Davis, Ian D; Scott, Andrew M 
1216-Nov-2004Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery.Schnurr, Max; Chen, Qiyuan; Shin, Amanda; Chen, Weisan; Toy, Tracey; Jenderek, Corinna; Green, Simon; Miloradovic, Lena; Drane, Debbie; Davis, Ian D; Villadangos, Jose; Shortman, Ken; Maraskovsky, Eugene; Cebon, Jonathan S 
1314-Oct-2004Extracellular nucleotide signaling by P2 receptors inhibits IL-12 and enhances IL-23 expression in human dendritic cells: a novel role for the cAMP pathway.Schnurr, Max; Toy, Tracey; Shin, Amanda; Wagner, Moritz; Cebon, Jonathan S ; Maraskovsky, Eugene